Andrew John Partridge - 14 Jul 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc.

Role
EVP & Chief Commercial Officer
Signature
/s/ Annette North, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
14 Jul 2021
Net transactions value
-$139,988
Form type
4
Filing time
15 Jul 2021, 17:53:20 UTC
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Sale $139,988 -1,869 -7.9% $74.90 21,767 14 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares of common stock to cover tax withholding obligations associated with vesting of a restricted stock unit award granted to Reporting Person on July 13, 2020.